Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

Gene expression profiling to identify parity-induced changes in the human mammary gland

Authors: I Verlinden, N Güngör, J Janssens, L Michiels

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

The protective effect of an early first full-term pregnancy in relation to breast cancer risk is well established, but the molecular and cell-specific changes in the human mammary gland remain unclear. The search for these early predictive markers for breast cancer risk is of high priority because these markers could identify women at increased risk and could monitor preventive strategies. …
Literature
1.
Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science. 1995, 270: 484-487.CrossRefPubMed
2.
Miksicek RJ, Myal Y, Watson PH, Walker C, Murphy LC, Leygue E: Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor mammary epithelium. Cancer Res. 2002, 62: 2736-2740.PubMed
Metadata
Title
Gene expression profiling to identify parity-induced changes in the human mammary gland
Authors
I Verlinden
N Güngör
J Janssens
L Michiels
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1123

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Oral Presentation

Targeting estrogen to kill ER-positive and ER-negative breast cancer

Oral Presentation

Potential mechanisms whereby estrogens induce breast cancer in women

Poster Presentation

DNA polymorphisms of several genes and predisposition to breast cancer

Poster Presentation

In vitro models for tumor protein d52 function in cancer cells

Oral Presentation

Molecular distinctions among ERBB2-overexpressing breast cancers

Oral Presentation

Genomic analysis of human breast cancer in families and populations
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits